VUB - TTI / Brussel / De Baetselie Scientific co / PET / Pleinlaan 2 / sdAbs / Sonja Haesen / Lahoutte Scientific co / When Molecular Diagnostics / / /
Event
FDA Phase / Business Partnership / /
IndustryTerm
radiochemistry and molecular imaging / generation technology / molecular imaging probes / pre-clinical imaging services / them as tools / biomedical applications / molecular imaging / imaging / animal imaging modalities / preclinical and clinical imaging diagnostics / in vivo imaging / therapeutics for cancer / molecular in vivo imaging / /
MedicalCondition
auto-immune diseases / arthritis / breast cancer / tumor / cancer / atherosclerosis / diabetes / immune diseases / experimental arthritis / infectious diseases / VHH FROM TARGET VALIDATION TO DISEASE IDENTIFICATION DECISIVE TRACERS FOR PERSONALIZED MEDICINE DECISIVE TRA PERSONALI CERS FOR ZED MEDIC INE ab / inflammation / HER2-positive tumor / /
Organization
Faculty of Sciences and Bio-engineering Sciences / Nuclear Medicine Department / Faculty of Medicine and Pharmacy / /
Person
Patrick De Baetselier / Raymond Hamers / Serge Muyldermans / Jan Steyaert / Lode Wyns / Nick Devoo / Patrickand / Tony Lahoutte / Ludwig amusot / Sonja Haesen / Nick Devoogdt / Ludwig Camusot / Patrick De / / /
Position
Director / /
Product
PET / Clinical Development Clinical Development Clinical Routine Compound / /
Camel-IDS IOF Knowle dge Center VHH